Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Antitumor agents from Taiho

Feb. 10, 1997

ADIR prepares antiangiogenic agents

Feb. 10, 1997

German researchers focus on Na+/H+-exchange inhibitors

Feb. 10, 1997

Antifungal agent revealed by Bayer

Feb. 10, 1997

Analgesic/antiinflammatory agent from Merck KGaA

Feb. 10, 1997

Dual-action compounds for BPH described by Zeria

Feb. 10, 1997

Gruenenthal prepares analgesics

Feb. 10, 1997

Legionella vaccine described by U.S. researchers

Feb. 7, 1997

Nonantiresorptive substituted bisphosphonate disclosed by Gador

Feb. 7, 1997

Antiallergic/antiinflammatory agents from Senju

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...